Patients with diabetes and obesity exhibit characteristics in eating and coping behaviors and personality traits

go back to reference Narayan KM, Boyle JP, Thompson TJ, Gregg EW, Williamson DF. Effect of BMI on lifetime risk for diabetes in the U.S. Diabetes Care. 2007;30:1562–6. Narayan KM, Boyle JP, Thompson TJ, Gregg EW, Williamson DF. Effect of BMI on lifetime risk for diabetes in the U.S. Diabetes Care. 2007;30:1562–6.

go back to reference Look AHEAD Research Group, Wing RR, Bolin P, Brancati L, Bray GA, Clark JM, Coday M, Crow RS, Curtis JM, Egan CM, Espeland MA, Evans M, Foreyt JP, Ghazarian S, Gregg EW, Harrison B, Hazuda HP, Hill JO, Horton ES, Hubbard VS, Jakicic JM, Jeffery RW, Johnson KC, Kahn SE, Kitabchi AE, Knowler WC, Lewis CE, Maschak-Carey BJ, Montez MG, Murillo A, Nathan DM, Patricio J, Peters A, Pi-Sunyer X, Pownall H, Reboussin D, Regensteiner JG, Rickman AD, Ryan DH, Safford M, Wadden TA, Wagenknecht LE, West DS, Williamson DF, Yanovski SZ. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369:145–54. Look AHEAD Research Group, Wing RR, Bolin P, Brancati L, Bray GA, Clark JM, Coday M, Crow RS, Curtis JM, Egan CM, Espeland MA, Evans M, Foreyt JP, Ghazarian S, Gregg EW, Harrison B, Hazuda HP, Hill JO, Horton ES, Hubbard VS, Jakicic JM, Jeffery RW, Johnson KC, Kahn SE, Kitabchi AE, Knowler WC, Lewis CE, Maschak-Carey BJ, Montez MG, Murillo A, Nathan DM, Patricio J, Peters A, Pi-Sunyer X, Pownall H, Reboussin D, Regensteiner JG, Rickman AD, Ryan DH, Safford M, Wadden TA, Wagenknecht LE, West DS, Williamson DF, Yanovski SZ. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369:145–54.

go back to reference Usui I. Common metabolic features of hypertension and type 2 diabetes. Hypertens Res. 2023;46:1227–33.CrossRefPubMed Usui I. Common metabolic features of hypertension and type 2 diabetes. Hypertens Res. 2023;46:1227–33.CrossRefPubMed

go back to reference ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Hilliard ME, Isaacs D, Johnson EL, Kahan S, Khunti K, Leon J, Lyons SK, Perry ML, Prahalad P, Pratley RE, Seley JJ, Stanton RC, Gabbay RA. Obesity and weight management for the prevention and treatment of type 2 diabetes: standards of care in diabetes-2023. Diabetes Care. 2023;46(Suppl 1):S128–39.CrossRefPubMed ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Hilliard ME, Isaacs D, Johnson EL, Kahan S, Khunti K, Leon J, Lyons SK, Perry ML, Prahalad P, Pratley RE, Seley JJ, Stanton RC, Gabbay RA. Obesity and weight management for the prevention and treatment of type 2 diabetes: standards of care in diabetes-2023. Diabetes Care. 2023;46(Suppl 1):S128–39.CrossRefPubMed

go back to reference Lingvay I, Sumithran P, Cohen RV, le Roux W. Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation. Lancet. 2022;399:394–405.CrossRefPubMed Lingvay I, Sumithran P, Cohen RV, le Roux W. Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation. Lancet. 2022;399:394–405.CrossRefPubMed

go back to reference Pastors JG, Warshaw H, Daly A, Franz M, Kulkarni K. The evidence for the effectiveness of medical nutrition therapy in diabetes management. Diabetes Care. 2002;25:608–13.CrossRefPubMed Pastors JG, Warshaw H, Daly A, Franz M, Kulkarni K. The evidence for the effectiveness of medical nutrition therapy in diabetes management. Diabetes Care. 2002;25:608–13.CrossRefPubMed

go back to reference Goldstein DJ. Beneficial health effects of modest weight loss. Int J Obes Relat Metab Disord. 1992;16:397–415.PubMed Goldstein DJ. Beneficial health effects of modest weight loss. Int J Obes Relat Metab Disord. 1992;16:397–415.PubMed

go back to reference Look AHEAD Research Group; Gregg EW, Jakicic JM, Blackburn G, Bloomquist P, Bray GA, Church T, Clark J, Coday M, Curtis JM, Egan C, Evans M, Foreyt JP, Foster G, Ghazarian S, Hazuda HP, Hill JO, Horton ES, Hubbard VS, Jeffery RW, Johnson KC, Khan SE, Kitabchi AE, Knowler WC, Kriska A, Lang W, Lewis CE, Montez MG, Nathan DM, Neiberg RH, Patricio J, Peters A, Pi-Sunyer X, Pownall H, Redmon B, Regensteiner J, Rejeski J, Ribisl PM, Safford M, Stewart K, Trence D, Wadden TA, Wing RR, Yanovski SZ. Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese patients with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol. 2016;4:913–21. Look AHEAD Research Group; Gregg EW, Jakicic JM, Blackburn G, Bloomquist P, Bray GA, Church T, Clark J, Coday M, Curtis JM, Egan C, Evans M, Foreyt JP, Foster G, Ghazarian S, Hazuda HP, Hill JO, Horton ES, Hubbard VS, Jeffery RW, Johnson KC, Khan SE, Kitabchi AE, Knowler WC, Kriska A, Lang W, Lewis CE, Montez MG, Nathan DM, Neiberg RH, Patricio J, Peters A, Pi-Sunyer X, Pownall H, Redmon B, Regensteiner J, Rejeski J, Ribisl PM, Safford M, Stewart K, Trence D, Wadden TA, Wing RR, Yanovski SZ. Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese patients with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol. 2016;4:913–21.

go back to reference Baum A, Scarpa J, Bruzelius E, Tamler R, Basu S, Faghmous J. Targeting weight loss interventions to reduce cardiovascular complications of type 2 diabetes: a machine learning-based post-hoc analysis of heterogeneous treatment effects in the Look AHEAD trial. Lancet Diabetes Endocrinol. 2017;5:808–15.CrossRefPubMedPubMedCentral Baum A, Scarpa J, Bruzelius E, Tamler R, Basu S, Faghmous J. Targeting weight loss interventions to reduce cardiovascular complications of type 2 diabetes: a machine learning-based post-hoc analysis of heterogeneous treatment effects in the Look AHEAD trial. Lancet Diabetes Endocrinol. 2017;5:808–15.CrossRefPubMedPubMedCentral

go back to reference Japan Society for the Study of Obesity. Guidelines for the Management of Obesity Disease 2022. Tokyo: Life Science; 2022. p. 8–17. (Japanese). Japan Society for the Study of Obesity. Guidelines for the Management of Obesity Disease 2022. Tokyo: Life Science; 2022. p. 8–17. (Japanese).

go back to reference ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Hilliard ME, Isaacs D, Johnson EL, Kahan S, Khunti K, Leon J, Lyons SK, Perry ML, Prahalad P, Pratley RE, Seley JJ, Stanton RC, Gabbay RA. Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2023. Diabetes Care. 2023;46(Suppl 1):S140–57.CrossRefPubMed ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Hilliard ME, Isaacs D, Johnson EL, Kahan S, Khunti K, Leon J, Lyons SK, Perry ML, Prahalad P, Pratley RE, Seley JJ, Stanton RC, Gabbay RA. Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2023. Diabetes Care. 2023;46(Suppl 1):S140–57.CrossRefPubMed

go back to reference Japan Society for the Study of Obesity. Guidelines for the Management of Obesity Disease 2022. Tokyo: Life Science; 2022. p. 64–5. (Japanese). Japan Society for the Study of Obesity. Guidelines for the Management of Obesity Disease 2022. Tokyo: Life Science; 2022. p. 64–5. (Japanese).

go back to reference Morita A, Aiba N, Miyachi M, Watanabe S, Saku Cohort Study Group. The associations of eating behavior and dietary intake with metabolic syndrome in Japanese: Saku cohort baseline study. J Physiol Anthropol. 2020;39:40. Morita A, Aiba N, Miyachi M, Watanabe S, Saku Cohort Study Group. The associations of eating behavior and dietary intake with metabolic syndrome in Japanese: Saku cohort baseline study. J Physiol Anthropol. 2020;39:40.

go back to reference Carver CS. You want to measure coping but your protocol’s too long: consider the brief COPE. Int J Behav Med. 1997;4:92–100.CrossRefPubMed Carver CS. You want to measure coping but your protocol’s too long: consider the brief COPE. Int J Behav Med. 1997;4:92–100.CrossRefPubMed

go back to reference Murakami H, Yasui-Furukori N, Otaka H, Nakayama H, Murabayashi M, Mizushiri S, Matsumura K, Tanabe J, Matsuhashi Y, Yanagimachi M, Sugawara N, K Shimoda K, Daimon M. Coping styles associated with glucose control in individuals with type 2 diabetes mellitus. J Diabetes Investig. 2020;11:1215–21. Murakami H, Yasui-Furukori N, Otaka H, Nakayama H, Murabayashi M, Mizushiri S, Matsumura K, Tanabe J, Matsuhashi Y, Yanagimachi M, Sugawara N, K Shimoda K, Daimon M. Coping styles associated with glucose control in individuals with type 2 diabetes mellitus. J Diabetes Investig. 2020;11:1215–21.

go back to reference Gosling SD, Rentfrow PJ, Swann WB Jr. A very brief measure of the Big-Five personality domains. J Res Pers. 2013;37:504–28.CrossRef Gosling SD, Rentfrow PJ, Swann WB Jr. A very brief measure of the Big-Five personality domains. J Res Pers. 2013;37:504–28.CrossRef

go back to reference Oshio A, Abe S, Cutrone P. Development, reliability, and validity of the Japanese version of Ten Item personality inventory (TIPI-J). Jpn J Pers. 2012;21:40–52. (Japanese). Oshio A, Abe S, Cutrone P. Development, reliability, and validity of the Japanese version of Ten Item personality inventory (TIPI-J). Jpn J Pers. 2012;21:40–52. (Japanese).

go back to reference Herdman M, Gudex C, Lloyd A, Janssen MF, Kind P, Parkin D, Bonsel G, Badia X. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20:1727–36.CrossRefPubMedPubMedCentral Herdman M, Gudex C, Lloyd A, Janssen MF, Kind P, Parkin D, Bonsel G, Badia X. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20:1727–36.CrossRefPubMedPubMedCentral

go back to reference Ikeda S, Shirowa T, Igarashi A, Noto S, Fukuda T, Saito S, Shimozuma K. Developing a Japanese verstion of the EQ-5D-5L velue set. J Natl Inst Public Health. 2015;64:47–55. (Japanese). Ikeda S, Shirowa T, Igarashi A, Noto S, Fukuda T, Saito S, Shimozuma K. Developing a Japanese verstion of the EQ-5D-5L velue set. J Natl Inst Public Health. 2015;64:47–55. (Japanese).

go back to reference Muramatsu K, Miyaoka H, Kamijima K, Muramatsu K, Miyaoka H, Kamijima K, Muramatsu Y, Tanaka Y, Hosaka M, Miwa Y, Fuse K, Yoshimine F, Mashima I, Shimizu N, Ito H, Shimizu E. Performance of the Japanese version of the Patient Health Questionnaire-9 (J-PHQ-9) for depression in primary care. Gen Hosp Psychiatry. 2018;52:64–9.CrossRefPubMed Muramatsu K, Miyaoka H, Kamijima K, Muramatsu K, Miyaoka H, Kamijima K, Muramatsu Y, Tanaka Y, Hosaka M, Miwa Y, Fuse K, Yoshimine F, Mashima I, Shimizu N, Ito H, Shimizu E. Performance of the Japanese version of the Patient Health Questionnaire-9 (J-PHQ-9) for depression in primary care. Gen Hosp Psychiatry. 2018;52:64–9.CrossRefPubMed

go back to reference Brummett BH, Babyak MA, Williams RB, Barefoot JC, Casta PT, Siegler IC. NEO personality domains and gender predict levels and trends in body mass index over 14 years during midlife. J Res Pers. 2006;40:222–36.CrossRef Brummett BH, Babyak MA, Williams RB, Barefoot JC, Casta PT, Siegler IC. NEO personality domains and gender predict levels and trends in body mass index over 14 years during midlife. J Res Pers. 2006;40:222–36.CrossRef

go back to reference Sutin AR, Stephan Y, Wang L, Gao S, Wang P, Terracciano A. Personality traits and body mass index in Asian populations. J Res Pers. 2015;58:137–42.CrossRefPubMedPubMedCentral Sutin AR, Stephan Y, Wang L, Gao S, Wang P, Terracciano A. Personality traits and body mass index in Asian populations. J Res Pers. 2015;58:137–42.CrossRefPubMedPubMedCentral